GlassScriptPhysician profile
Heraj Patel
NPI 1225380462
$4,604.03
in general payments reported to CMS, 2019-2025
28 companies · $968 in 2025
The $968 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,229 · 2020: $239 · 2021: $112 · 2022: $562 · 2023: $558 · 2024: $936 · 2025: $968.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,462.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $1,043.74 | 2019-2024 | Portfolio, R3flex, Jaws |
| Nevro Corp. | $884.62 | 2022-2024 | Senza |
| Amgen INC. | $583.22 | 2024-2025 | Krystexxa |
| Wright Medical Technology, INC. | $191.45 | 2019-2020 | |
| Bioventus LLC | $186.43 | 2019-2025 | Exogen Ultrasound Bone Healing System, Supartz Fx Sodium Hyaluronate |
| Sebela Pharmaceuticals INC. | $146.13 | 2022-2023 | Naftin |
| Depuy Synthes Sales INC. | $144.18 | 2019-2025 | Minibunion |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $135.54 | 2019-2025 | Jublia, Siliq, Cabtreo |
| Abbvie INC. | $127.38 | 2024-2025 | |
| Angiodynamics, INC. | $126.52 | 2025 | Auryon Laser System 100-120 Vac |
| Novartis Pharmaceuticals Corporation | $119.75 | 2019 | |
| Averitas Pharma INC. | $117.91 | 2023-2025 | Qutenza |
| Globus Medical, INC. | $96.17 | 2025 | Senza |
| Stryker Corporation | $92.74 | 2020-2025 | Easyfuse |
| Abbott Laboratories | $80.15 | 2021-2025 | Proclaim |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $77.62 | 2019-2023 | Krystexxa |
| Treace Medical Concepts, INC. | $74.94 | 2022-2024 | |
| Orthofix Medical, INC. | $62.83 | 2019-2024 | Spinal-Stim, Cervical-Stim, Physio-Stim |
| Merck Sharp & Dohme LLC | $58.00 | 2019 | |
| Innovation Technologies INC | $35.09 | 2021-2024 | Irrisept |
| Ibsa Pharma INC. | $34.68 | 2023-2024 | Tirosint, Tirosint, Flector |
| Grt US Holding, INC. | $32.37 | 2022 | |
| Sandoz INC. | $31.22 | 2019 | |
| Organogenesis INC. | $29.94 | 2024 | |
| Kerecis Limited | $25.41 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Paratek Pharmaceuticals, INC. | $24.55 | 2024 | Nuzyra |
| Mimedx Group, INC. | $22.30 | 2024 | |
| Musculoskeletal Transplant Foundation INC. | $19.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heraj Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.